Skip to content

Improving Cognitive Rehabilitation Outcomes

Improving Cognitive Rehabilitation Outcomes for Veterans With mTBI+PTSD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07055633
Enrollment
144
Registered
2025-07-09
Start date
2026-04-01
Completion date
2030-09-30
Last updated
2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Traumatic Brain Injury, Posttraumatic Stress Disorder

Keywords

brain injury, posttraumatic stress disorder

Brief summary

Posttraumatic stress disorder (PTSD) and mild TBI (mTBI) frequently co-occur in post-9/11 Veterans, and together are associated with worse cognitive performance, mental health, everyday functioning, community integration, quality of life, and treatment response than either condition alone. Additional comorbidities, such as depression and sleep disturbance, are common and further exacerbate these problems. The investigators will investigate Compensatory Cognitive Training (CCT) and Morning Bright Light Therapy (MBLT) vs Negative Ion Generator (ION), to directly target cognition, depression, and sleep disturbance and to improve CCT-associated rehabilitation outcomes. The investigator's randomized controlled trial in 144 Veterans with mTBI+PTSD across two VA sites will compare cognition, functioning, and other secondary outcomes following CCT+MBLT vs. CCT+ION. This study addresses the significant gap in services and evidence-based treatments for Veterans with mTBI+PTSD.

Detailed description

The investigators aim to compare CCT+MBLT with CCT+ION for improving cognition, functioning, and secondary outcomes in Veterans with mTBI+PTSD. Objective cognitive performance and everyday functioning are co-primary outcomes. Depression and sleep disturbance are target mechanisms and secondary outcomes include PTSD symptom severity, post-concussive symptom severity, cognitive symptom severity, and quality of life. Improvements in mood and sleep will be investigated as mediators. To explore for whom these interventions are most effective, the investigators will evaluate whether individual difference variables (e.g., demographics, premorbid functioning, treatment adherence) or baseline performance on primary and secondary outcome measures moderate intervention-related improvements in objective cognitive performance and everyday functioning. The investigators will enroll a representative sample of 144 post-9/11 Veterans with mTBI+PTSD at two VA sites (San Diego and Portland). Assessments will be conducted at baseline, mid-treatment (5 weeks), post-treatment (10 weeks), and three-month follow-up.

Interventions

DEVICECCT+MBLT

Compensatory Cognitive Training + Morning Bright Light Therapy (Aurora LightPad)

DEVICECCT+ION

Compensatory Cognitive Training + Negative Ion Generator (SphereOne)

Sponsors

VA Office of Research and Development
Lead SponsorFED
Portland VA Medical Center
CollaboratorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

CCT+MBLT vs CCT+ION

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Post 9/11 Veterans enrolled at VA San Diego or VA Portland * Ability to provide informed consent * Living independently * History of mTBI confirmed by OSU-TBI * Current diagnosis of PTSD confirmed by CAPS-5 * Current cognitive concerns ("Do you have concerns about your cognition, thinking, attention, or memory?") * Current concern regarding depression and/or sleep disturbance; defined by a score of 5 on the PHQ-9 and/or 8 on the ISI, respectively (score of 2 or higher on ISI item 1, 2, or 3, reflecting at least "moderate" difficulty with falling asleep, staying asleep, or waking up too early in the morning)

Exclusion criteria

* Current substance use disorder with \<30 days abstinence * History of primary psychotic disorder * History of moderate to severe TBI (loss of consciousness \>30 minutes) * History of macular degeneration or bipolar disorder (both contraindicated for bright light therapy) * Not work night or swing shift schedules * Untreated obstructive sleep apnea either via self-report or a score 5 on the STOP-BANG * Current engagement in bright light therapy * Auditory or visual impairments precluding participation in assessments or treatments

Design outcomes

Primary

MeasureTime frameDescription
Objective Cognitive Performancebaseline, 10 weeksComposite z score of Hopkins Verbal Learning Test-Revised; Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) Digit Span; WAIS-IV Coding; Delis-Kaplan Executive Function System (D-KEFS) Trails; D-KEFS Color-Word Interference; and the UCSD Performance-Based Skills Assessment-Brief (UPSA-B). There is no minimum or maximum value of a z score. Higher scores will reflect better outcomes.
Functioningbaseline, 10 weeksComposite z score of Brief Inventory of Psychosocial Functioning and the World Health Organization Disability Assessment Schedule 2.0. There is no minimum or maximum value of a z score. Higher scores will reflect better outcomes.

Secondary

MeasureTime frameDescription
Insomnia Severity Indexbaseline, 10 weeksInsomnia severity. Scores range from 0-28, with higher scores representing worse insomnia.
Pittsburgh Sleep Quality Indexbaseline, 10 weeksSleep quality. Scores range from 0-21, with higher scores representing worse sleep quality.
Total Sleep Timebaseline, 10 weeksTotal Sleep Time derived from Actiwatch2. Minutes range from 0 to 1440 per day, with higher numbers reflecting more minutes of sleep.
Patient Health Questionnaire-9baseline, 10 weeksDepression symptom severity. Scores range from 0-27, with higher scores reflecting worse depression symptoms.
PTSD Checklist for DSM-5baseline, 10 weeksPTSD symptom severity. Scores range from 0-80, with higher scores reflecting worse PTSD symptoms.
Neurobehavioral Symptom Inventorybaseline, 10 weeksPostconcussive symptom severity. Scores range from 0-88, with higher scores reflecting worse neurobehavioral symptoms.
Subjective cognitive functioningbaseline, 10 weeksMean score across Neuro-QOL Applied Cognition Executive Function and Neuro-QOL Applied Cognition General Concerns scales. The mean score has a range of 8-40, with higher scores reflecting better subjective cognitive functioning.
World Health Organization Quality of Lifebaseline, 10 weeksQuality of life. Scores range from 0-100, with higher scores reflecting better quality of life.

Countries

United States

Contacts

CONTACTMichelle Z Schy
michelle.schy@va.gov(858) 255-4368
CONTACTJanae R Wyckoff
janae.wyckoff@va.gov(619) 786-4719
PRINCIPAL_INVESTIGATORElizabeth W. Twamley, PhD

VA San Diego Healthcare System, San Diego, CA

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 25, 2026